Why does being on your own seem so expensive? The number of unmarried, divorced, widowed or unattached people is growing worldwide. But figures suggest it is more financial costly to be single, while couples and families benefit from paying less per person. Whether it is the packaging supermarkets use, streaming service tariffs, hotel rooms - you often get a much better deal being coupled-up than not. Governments are in on the act too: offering tax breaks to couples.In this programme, we take apart the personal finances of singles; hearing from World Service listeners and financial analysts. Is it just economies of scale or are we really living in a world that penalises people on their own? And are there any financial advantages to being solo?(Picture: Senior woman looking concerned, paying bills at home on her laptop. Credit: Getty Images)Presented and produced by David Reid
Folgen von Business Daily
2000 Folgen
-
Folge vom 11.06.2024Is there a penalty for being single?
-
Folge vom 10.06.2024Economic life in PalauWe look at how soaring food and fuel prices are affecting the tiny island nation in the western Pacific Ocean.Like much of the world, the Covid-19 pandemic and the war in Ukraine have led to supply chain issues, and rising costs.And with limited opportunities, young people are facing the question, should they stay or leave and chase careers elsewhere?Produced and presented by Frey Lindsay(Image: People gathered under the Japan-Palau Friendship bridge in Koror, Palau. Credit: Frey Lindsay/BBC)
-
Folge vom 09.06.2024The fight over Palau's oceansWe travel to the tiny pacific nation which wants to shrink its marine sanctuary, and open it up once more to commercial fishing.The President says it’s costing too much in lost revenue, when Palauans are already struggling.But opponents say this goes against Palau's conservationist ethos.So today we're asking - can conservation and commerce, co-exist?Produced and presented by Frey Lindsay(Image: The National Geographic Pristine Seas research vessel the Argo, in the Pacific Ocean East of Palau. Credit: Frey Lindsay)
-
Folge vom 06.06.2024The weight-loss drug revolutionDiabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of Mounjaro. But with competitors desperate for a piece of the action, how long can these two giants stay in front?Leanna Byrne hears from some of the companies involved, including those at the centre of the action and those developing the next wave of treatments.Presented by Leanna Byrne and produced by Lexy O'Connor(Image: A box of the anti-obesity drug Wegovy, including injection pens. Credit: Getty Images)